Atossa Genetics Announces Launch of ArgusCYTE Breast Health Test(SM) for Detection of Circulating Tumor Cells SEATTLE, WA--(Marketwire - Dec 6, 2011) - Atossa Genetics, Inc., a health care company developing and commercializing a comprehensive set of innovative, proprietary breast health evaluation...